Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02029989 · ClinicalTrials.gov registry record · NA
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT02029989 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 121 participants.
The verdict
NCT02029989, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
The study was a 12-month, multi-centered, quasi-experimental design to assess point-of-care (POCT) screening/monitoring of subjects on antipsychotic agents for metabolic syndrome. Subjects were also randomized to either an Extended Treatment Group (ETG) defined by receiving comprehensive medication management (CMM) pharmacist interventions or a Usual Treatment Group (UTG) receiving no CMM interventions. All subjects were recruited from three community mental health clinic settings in Minnesota.
Interventions
- DEVICE Glucose and lipids
- DEVICE Glycosylated Hemoglobin A1c
- DEVICE Blood Pressure and Heart Rate
- DEVICE Body mass index
- DEVICE Waist and Hip circumference
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02029989
The ClinicalTrials.gov registry entry for NCT02029989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Glucose and lipids is the first listed.
NCT02029989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02029989 about?
NCT02029989 is a clinical study titled "Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness". The study was a 12-month, multi-centered, quasi-experimental design to assess point-of-care (POCT) screening/monitoring of subjects on antipsychotic agents for metabolic syndrome. Subjects were also randomized to either an Extended Treatment Group (ETG) defined by receiving comprehensive medication ...
What is the current status of trial NCT02029989?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2010-02. Estimated completion is 2012-02.
What interventions are being tested in trial NCT02029989?
The interventions under investigation include: Glucose and lipids (DEVICE), Glycosylated Hemoglobin A1c (DEVICE), Blood Pressure and Heart Rate (DEVICE), Body mass index (DEVICE), Waist and Hip circumference (DEVICE).
Who is sponsoring clinical trial NCT02029989?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.